PATENT CLAIM ANALYSIS

Application Number: 15939604
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "019600"]

Abstract:
Provided are peptides, compositions comprising the peptides, and methods of using the peptide compositions for inhibition of growth of cancer cells. The peptides comprise a sequence of ARX 1 X 2 X 3 X 4 , and inhibit or disrupt the formation of MLL1 and SET1 complexes.

Claim (Index 8):
A composition comprising a peptide of  claim 1  and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.45714
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12509874', '13415474', '15185299', '13160086', '13569583']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.733862666430982
- 35 USC 102 Novelty (BERT): 0.5700339249515244
- Combined Prediction Score: 0.7174797922830362
- Mean Citation Score: 350.393684
- Max Citation Score: 482.3067
- Similarity Product: 333.13423717140546

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test